Dechert advises ARCHIMED on Acquisition of a Majority Stake in Stago Group

Dechert advised ARCHIMED, one of the leading international private equity firms specializing in the healthcare sector, in connection with its acquisition of a majority stake in the Stago group, a global leader in diagnostics and a specialist in hemostasis. La Caisse (formerly Caisse de dépôt et placement du Québec) will invest alongside ARCHIMED as a minority investor.

The Dechert team advising ARCHIMED included partner Alain Decombe along with associates Vianney Toulouse, Yona Elfassi and Anaïs Fritzinger on transactional aspects; partner Mélanie Thill-Tayara along with partners Marion Provost, Clemens York, Saira Henry, James Fishkin, counsel Beverly Ang and associates Dieynaba Kane, Charles Sauvage, Victor Sampaio and Thirith von Döhren on merger control aspects; partner Sophie Pelé with associate Margaux Lasseigne on regulatory and FDI matters; partner Privat Vigand with associate Chloé Lebret on financing aspects; partner Sabina Comis along with associates Etienne Bimbeau and Pierre-Emmanuel Floc’h on tax and structuring matters; national partner Thibault Meiers on labor matters; and partners Noah Leibowitz and Tom Rayski with associate Frank Hwang on the US IP aspects.

About Dechert

Dechert is the law firm that helps business leaders lead.

For more than 150 years, we have advised clients on critical issues – from high-stakes litigation to first-in-market transaction structures and complex regulatory matters. Our lawyers in commercial centers worldwide are immersed in the key sectors we serve – financial services, private capital, real estate, life sciences and technology.

Dechert delivers unwavering partnership so our clients can achieve unprecedented results.

Dechert’s Paris office is a key component of the firm's strategy in Europe and is active in antitrust/competition and European law, corporate/M&A, financial services & asset management, financing, intellectual property, labor and employment, litigation and compliance, regulatory and tax.

Dechert’s life sciences team in France represents companies ranging from multinational giants to emerging companies involving all aspects of the life sciences industry, including pharmaceuticals, biotechnology, drug discovery, genomics, biopharmaceuticals, diagnostics, medical devices and health care. We also assist investment funds with life sciences investments. Read more »